Conclusion
The exploration of cardiac ion channelopathies and SCD across diverse
populations has illuminated significant disparities in healthcare
access, treatment effectiveness, and genetic understanding. Studies
focusing on AA and Asian populations have revealed underrepresentation
in clinical trials and socioeconomic factors contributing to increased
SCD risk. Similarly, the dearth of research in Hispanic/Latino and
Indigenous populations underscores the urgent need for comprehensive
studies to address genetic risk factors and socioeconomic disparities
affecting SCD susceptibility. Despite the challenges, recent
investigations have shed light on the prevalence and risk factors of
arrhythmias in Hispanic/Latino and Indigenous communities, offering
valuable insights into potential cardioprotective factors and genetic
variants associated with these conditions. Moving forward, collaborative
efforts involving international and inter-institutional studies are
essential to establish consensus on genetic influences and develop
targeted interventions tailored to various ethnic subgroups. By
prioritizing research in these underserved populations, significant
progress towards bridging healthcare disparities and improving outcomes
for individuals affected by cardiac ion channelopathies across diverse
ethnicities can be achieved.